Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

sistema corporativo deutzia, s.a. de c.v. - ethyl alcohol 70%, anticeptic - to decrease bacteria on the skin that could cause disease. recommended for repeated use.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

mylan specialty l.p. - pretomanid (unii: 2xoi31yc4n) (pretomanid - unii:2xoi31yc4n) - limited population: pretomanid tablet is indicated, as part of a combination regimen with bedaquiline and linezolid for the treatment of adults with pulmonary tuberculosis (tb) resistant to isoniazid, rifamycins, a fluoroquinolone and a second line injectable antibacterial drug or adults with pulmonary tb resistant to isoniazid and rifampin, who are treatment-intolerant or nonresponsive to standard therapy. approval of this indication is based on limited clinical safety and efficacy data. this drug is indicated for use in a limited and specific population of patients. limitations of use: pretomanid tablets used in the combination regimen with bedaquiline and linezolid are contraindicated in patients for whom bedaquiline and/or linezolid are contraindicated. refer to the bedaquiline and linezolid prescribing information. there are no studies or available data on pretomanid use in pregnant women to inform any drug-associated risks. there are risks associated with active tuberculosis during pregnancy (see cl

Europos Sąjunga - anglų - EMA (European Medicines Agency)

mylan ire healthcare limited - pretomanid - tuberculosis, multidrug-resistant - antimycobacterials - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb).consideration should be given to official guidance on the appropriate use of antibacterial agents.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

breathing and medical - 37706 - breathing circuit, ventilator, single use - a single use device for conducting air or oxygen enriched gas from a ventilator to a patient.

Europos Sąjunga - anglų - EMA (European Medicines Agency)

teva b.v. - colistimethate sodium - cystic fibrosis - antibacterials for systemic use, - colobreathe is indicated for the management of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged six years and older.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

mylan specialty lp - pretomanid (unii: 2xoi31yc4n) (pretomanid - unii:2xoi31yc4n) - limited population: pretomanid tablet is indicated, as part of a combination regimen with bedaquiline and linezolid for the treatment of adults with pulmonary extensively drug resistant (xdr) or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). approval of this indication is based on limited clinical safety and efficacy data. this drug is indicated for use in a limited and specific population of patients. limitations of use: - pretomanid tablets are not indicated in patients with the following conditions: drug-sensitive (ds) tuberculosis latent infection due to mycobacterium tuberculosis. extra-pulmonary infection due to mycobacterium tuberculosis. mdr-tb that is not treatment-intolerant or nonresponsive to standard therapy. - drug-sensitive (ds) tuberculosis - latent infection due to mycobacterium tuberculosis. - extra-pulmonary infection due to mycobacterium tuberculosis. - mdr-tb that is not treatment-intolerant or nonresponsive to stan

Europos Sąjunga - anglų - myHealthbox

forest laboratories uk ltd - colistimethate sodium - inhalation powder, hard capsule - each capsule contains 1662500iu (approximately equal to 125mg) of colistimethate sodium - cystic fibrosis - antibacterials for systemic use - colobreathe is indicated for the management of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged 6 years and older

Australija - anglų - Department of Health (Therapeutic Goods Administration)

draeger australia pty ltd - 34877 - breathing circuit bag, anaesthesia, single use - breathing bag system intended for use with anesthesia machines, as a reservoir during automatic ventilation and as a breathing bag during manual ventilation. intended for single-use only.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

draeger australia pty ltd - 37706 - breathing circuit, ventilator, single use - breathing circuit for conveying respiratory gases between an anesthesia machine or ventilator and an adult patient. intended for single-use only. breathing circuit with integrated transponder. the transponder serves as a carrier of product-specific data for processing by dr?ger infinity id equipment. intended for single-use only.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

teleflex medical australia pty ltd - 37704 - breathing circuit, anaesthesia, single use - breathing circuit for anaesthesia and reanimation for patients in assisted ventilation.